| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Mesa Laboratories, Inc. (MLAB) have been net buyers, picking up 900 shares worth roughly $102K on balance.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 19.8K | $2.48M | - | |
| Dir | 19.4K | $2.44M | - | |
| Dir | 12.3K | $1.55M | - | |
| Dir | 9.1K | $1.14M | - | |
| Dir | 7.7K | $961.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2021 | Evan Guillemin68 | Director | Sell | 720 | $269.48 | $194,025.60 | -2.2% | -0.3% | -2.8% | |
| Mar 12, 2021 | John Sakys79 | CFO | Sale+OE | 2,500 | $263.84 | $659,600.00 | -36.5% | -1.8% | -7.3% | |
| Mar 10, 2021 | Brian David Archbold69 | SVP Continuous Improvement | Sale+OE | 223 | $271.78 | $60,606.94 | -59.2% | -4.2% | -5.8% | |
| Mar 1, 2021 | John James Sullivan69 | Director | Sell | 1,250 | $273.94 | $342,425.00 | -2.1% | - | - | |
| Feb 23, 2021 | Gregory Dinoia64 | SVP Commericial | Sell | 280 | $276.75 | $77,490.00 | -25.0% | - | - | |
| Feb 16, 2021 | Evan Guillemin68 | Director | Sell | 3,600 | $281.52 | $1,013,472.00 | -9.9% | - | - | |
| Feb 10, 2021 | John Bradley Schmieder69 | Director | Sell | 1,750 | $278.23 | $486,902.50 | -2.4% | - | - | |
| Feb 1, 2021 | John James Sullivan69 | Director | Sell | 1,250 | $277.67 | $347,087.50 | -2.1% | - | - | |
| Jan 12, 2021 | John Bradley Schmieder69 | Director | Sell | 477 | $285.23 | $136,054.71 | -0.6% | - | - | |
| Jan 6, 2021 | John Sakys79 | CFO | Sale+OE | 16 | $290.00 | $4,640.00 | -0.5% | - | - |